Evidence map›Paper›PMID 25340353›Full record

ArticlePloS one2014

A murine inhalation model to characterize pulmonary exposure to dry Aspergillus fumigatus conidia.

Amanda D Buskirk, Brett J Green, Angela R Lemons, Ajay P Nayak, W Travis Goldsmith, Michael L Kashon, Stacey E Anderson, Justin M Hettick, Steven P Templeton, Dori R Germolec and 1 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Impact of CD11cFrontiers in fungal biology · 2025
    Article
  4. Review
  5. Optimization ofJournal of fungi (Basel, Switzerland) · 2023
    Article
  6. Strategies for Monitoring Microbial Life in Beach Sand for Protection of Public Health.International journal of environmental research and public health · 2023
    Review
  7. PersistingFrontiers in cellular and infection microbiology · 2023
    Article
  8. Journal of fungi (Basel, Switzerland) · 2022
    Review
  9. Review
  10. Inhalation ofAmerican journal of respiratory cell and molecular biology · 2020
    Article
  11. Article
  12. Animal Models to Study Mucormycosis.Journal of fungi (Basel, Switzerland) · 2019
    Review
  13. Aspergillus fumigatus viability drives allergic responses to inhaled conidia.Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology · 2018
    Article
  14. Article
  15. Review
  16. Rodent Models of Invasive Aspergillosis due toFrontiers in microbiology · 2017
    Review
  17. Influence of Aspergillus fumigatus conidia viability on murine pulmonary microRNA and mRNA expression following subchronic inhalation exposure.Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2016
    Article
  18. Subchronic exposures to fungal bioaerosols promotes allergic pulmonary inflammation in naïve mice.Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2016
    Article
  19. Review
  20. ASN neuro
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Amanda D BuskirkAllergy and Clinical Immunology Branch, Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Morgantown, West Virginia, United States of America.
Brett J GreenAllergy and Clinical Immunology Branch, Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Morgantown, West Virginia, United States of America.
Angela R LemonsAllergy and Clinical Immunology Branch, Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Morgantown, West Virginia, United States of America.
Ajay P NayakAllergy and Clinical Immunology Branch, Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Morgantown, West Virginia, United States of America.
W Travis GoldsmithPathology and Physiology Research Branch, Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Morgantown, West Virginia, United States of America.
Michael L KashonBiostatistics and Epidemiology Branch, Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Morgantown, West Virginia, United States of America.
Stacey E AndersonAllergy and Clinical Immunology Branch, Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Morgantown, West Virginia, United States of America.
Justin M HettickAllergy and Clinical Immunology Branch, Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Morgantown, West Virginia, United States of America.
Steven P TempletonAllergy and Clinical Immunology Branch, Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Morgantown, West Virginia, United States of America.
Dori R GermolecToxicology Branch, National Toxicology Program Division, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina, United States of America.
Donald H BeezholdAllergy and Clinical Immunology Branch, Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Morgantown, West Virginia, United States of America.
National Institute for Occupational Safety and Health · USCenters for Disease Control and Prevention · USNational Institute of Environmental Health Sciences · US

Funding

PHS HHS AES 12007-00100000
6 · The paper itself

Abstract

Most murine models of fungal exposure are based on the delivery of uncharacterized extracts or liquid conidia suspensions using aspiration or intranasal approaches. Studies that model exposure to dry fungal aerosols using whole body inhalation have only recently been described. In this study, we aimed to characterize pulmonary immune responses following repeated inhalation of conidia utilizing an acoustical generator to deliver dry fungal aerosols to mice housed in a nose only exposure chamber. Immunocompetent female BALB/cJ mice were exposed to conidia derived from Aspergillus fumigatus wild-type (WT) or a melanin-deficient (Δalb1) strain. Conidia were aerosolized and delivered to mice at an estimated deposition dose of 1×105 twice a week for 4 weeks (8 total). Histopathological and immunological endpoints were assessed 4, 24, 48, and 72 hours after the final exposure. Histopathological analysis showed that conidia derived from both strains induced lung inflammation, especially at 24 and 48 hour time points. Immunological endpoints evaluated in bronchoalveolar lavage fluid (BALF) and the mediastinal lymph nodes showed that exposure to WT conidia led to elevated numbers of macrophages, granulocytes, and lymphocytes. Importantly, CD8+ IL17+ (Tc17) cells were significantly higher in BALF and positively correlated with germination of A. fumigatus WT spores. Germination was associated with specific IgG to intracellular proteins while Δalb1 spores elicited antibodies to cell wall hydrophobin. These data suggest that inhalation exposures may provide a more representative analysis of immune responses following exposures to environmentally and occupationally prevalent fungal contaminants.

Indexed as

Inhalation ExposureAcousticsAdministration, InhalationAnimalsAntibodies, FungalAntibody FormationAspergillus fumigatusBronchoalveolar Lavage FluidCell CountCell ProliferationCytokinesDisease Models, AnimalFemaleFlow CytometryHyphaeImmunoglobulin GAntibodies, FungalCytokinesImmunoglobulin G

Identifiers

PMID25340353
PMCPMC4207673
OpenAlexW2069640533

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.